previous compound ID: 109 next compound
InChIKey: AEMFNILZOJDQLW-QAGGRKNESA-N
SMILES: C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "J Liao" "D Rotin" "E Matthes" "J Goepp" "DY Thomas" "R Robert" "B Kus" "JW Hanrahan" "SD Macknight"

chemical graph of compound 109





CID is 6128
synonyms found at PubChem are:
androstenedione, 4-Androstene-3,17-dione, Androst-4-ene-3,17-dione, 63-05-8, 4-Androstenedione, Androtex, 3,17-Dioxoandrost-4-ene, delta-4-Androstenedione, SKF 2170, Fecundin, delta-4-Androsten-3,17-dione, delta-4-Androstene-3,17-dione, 4-ANDROSTENE-3-17-DIONE, 4-Androsten-3,17-dione, NSC 9563, delta-(sup4)-Androsten-3,17-dione, delta(sup 4)-Androstene-3,17-dione, 17-Ketotestosterone, UNII-409J2J96VR, d4-androstenedione, CHEBI:16422, Androstenedione [JAN], HSDB 7335, EINECS 200-554-5, MLS000028510, Delta(4)-androsten-3,17-dione, NSC9563, AEMFNILZOJDQLW-QAGGRKNESA-N, 409J2J96VR, Delta(4)-androstene-3,17-dione, .DELTA.4-Androstene-3,17-dione, (8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione, Androstenedione (JAN), NCGC00023902-06, SMR000058281, DSSTox_CID_4523, DSSTox_RID_77443, DSSTox_GSID_24523, CAS-63-05-8, (8R,9S,10R,13S,14S)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione, 117598-81-9, ASD, CHEMBL274826, adione, delta4-androstenedione, Androsten-3,17-dione, AC1L1LUU, Opera_ID_1694, Spectrum5_002059, [4-14C]-androstenedione, D03TIX, D0M8RO, D0O3GO, Epitope ID:135869, EC 200-554-5, AC1Q6O8G, androst-4-en-3,17-dione, BIDD:PXR0101, D4-Androstene-3,17-dione, Lopac0_000114, SCHEMBL23272, KSC353K6T, MLS000563086, MLS002152886, (4)-Androsten-3,17-dione, GTPL2860, DTXSID8024523, BDBM91713, CTK2F3569, DELTA4-Androstene-3,17-dione, .delta.4-Androsten-3,17-dione, Androst-4-en-3,17-dione, 2, HMS2231F18, NSC-9563, ZINC4428526, Tox21_110893, Tox21_202269, Tox21_300579, BBL033517, c1015, LMST02020007, MFCD00003615, STK801871, AKOS005622710, Tox21_110893_1, [4-14C]androst-4-ene-3,17-dione, CCG-204209, DB01536, LS-2167, MCULE-8902385122, RTR-021722, SHG0000068, .delta.-(sup4)-Androsten-3,17-dione, Estr-5-ene-3,17-diol,(3b,17b)-, NCGC00023902-03, NCGC00023902-04, NCGC00023902-05, NCGC00023902-07, NCGC00023902-08, NCGC00023902-09, NCGC00254238-01, NCGC00259818-01, AC-11042, Androstenedione; 3,17-Dioxo-4-andostene, SC-46873, AB0090630, DB-054395, KB-145875, A0845, androst-4-ene-3,17-dione (androstenedione), EU-0100114, FT-0082072, FT-0657562, Androstenedione (Androst-4-ene-3,17-dione), WLN: L E5 B666 FV OV MUTJ A1 E1, A 9630, C00280, D00051, SR-01000003096, SR-01000075697, SR-01000003096-4, SR-01000075697-1, W-104936, I14-14300, 8F5F4DCB-1164-4F2C-B4E3-3B74F684B189, 4-Androstene-3,17-dione, VETRANAL(TM), analytical standard, Androstenedione (Androst-4-ene-3,17-dione) 1.0 mg/ml in Acetonitrile, 104534-78-3